Drug
Idarubicin And Lipiodol
Idarubicin And Lipiodol: highest development phase Phase 2, developed by Guerbet. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| Idarubicin and Lipiodol NCT03727633 | Phase 2 | Carcinoma, Hepatocellular |
Latest
No recent events.
Follow Idarubicin And Lipiodol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.